Patent · US Active

Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use

US10125189B2 · kind B2 · utility

3Cited by
13References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 16, 2015
Grant dateNov 13, 2018
Priority date
Expiry dateMay 19, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/21
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a new and improved method for preparing a highly concentrated immunoglobulin composition from pooled plasma for subcutaneous injection. A composition comprising 20% or more immunoglobulin suitable for subcutaneous use is also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.